| Literature DB >> 25848279 |
Carmen Sílvia Miguel1, Tiffany M Chaim-Avancini1, Maria Aparecida Silva1, Mario Rodrigues Louzã1.
Abstract
BACKGROUND: The cognitive profile of children with neurofibromatosis type 1 (NF1) and attention deficit hyperactivity disorder (ADHD) has been well characterized, but few studies have evaluated the cognitive abilities of adults with NF1 and ADHD.Entities:
Keywords: ADHD; NF1; cognition; executive function; low-grade pontine glioma
Year: 2015 PMID: 25848279 PMCID: PMC4378869 DOI: 10.2147/NDT.S75038
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Results obtained on cognitive variables by the patient at baseline and at 14 months’ follow-up
| Achieved measures Mean (± SD) Scores*
| Expected measures Mean (± SD) Scores* | ||
|---|---|---|---|
| Baseline | At 14 months | ||
| MMSE | 28 | 30 | 27.17 (±1.94) |
| Stroop I | 16 | 19 | 11.79 (±2.79) |
| Stroop II | 21 | 18 | 13.46 (±3.11) |
| Stroop III | 20 | 28 | 21.28 (±5.37) |
| Block design (WAIS-R) | 8 | 8 | 10 |
| Vocabulary (WAIS-R) | 8 | 8 | 10 |
| TMT-A | 48 | 31 | 27.4 (±9.6) |
| TMT-B | 73 | 49 | 58.7 (±15.9) |
| ROCF – Copy | 23 | 25 | 32.82 (±3.19) |
| FAS | 26 | 28 | 44.7 (±11.2) |
| RAVLT I | 5 | 6 | 6.19 (±1.62) |
| RAVLT II | 9 | 7 | 8.78 (±1.91) |
| RAVLT III | 10 | 8 | 9.88 (±1.70) |
| RAVLT IV | 12 | 8 | 11.88 (±1.70) |
| RAVLT V | 14 | 10 | 12.59 (±1.62) |
| Total RAVLT I to V | 50 | 40 | 49.31 (±6.14) |
| RAVLT (Interference) | 3 | 3 | 4.47 (±1.50) |
| RAVLT VI (Immediate recall) | 11 | 9 | 10.84 (±1.85) |
| RAVLT VII (Delayed recall) 30′ | 10 | 10 | 10.34 (±2.13) |
| ROCF (Delayed recall) 30′ | 22 | 7 | 18.70 (±6.64) |
| WCST (Categories) | 3 | 2 | 4 |
| CPT omissions | 46.88 | 49.76 | 45–54 |
| CPT commissions | 48.31 | 50.49 | 45–54 |
| CPT reaction time | 50.34 | 53.90 | 45–54 |
| Digit Span Forward/Backward – total (WAIS-III) | 10 | 14 | 10 |
| Digit Span Forward (WAIS-III) | 8 | 13 | Not available |
| Digit Span Backward (WAIS-III) | 5 | 6 | Not available |
| LNS (WAIS-III) | Not applied | 11 | 10 |
| Catergory Test (animals) | Not applied | 26 | 15.88 (±4.25) |
Notes: The patient showed a decline in performance over time in the RAVLT Test; trails IV, V, and total from I to V (learning); ROCF Test (visual delayed recall); Stroop I and III tests (selective attention and inhibitory control); and WCST Task (categories; difficulty in selecting adequate answers in response to demands of the environment). The patient showed improved performance over time in the ROCF copy (visuospatial function) and Stroop II Test (selective attention). The patient showed unchanged performance in the Block Design Test (designed to be a non verbal IQ test), Vocabulary Test (designed to be a verbal IQ test), and FAS Test (phonetic fluency). The patient’s cognitive performance ranged from superior average to inferior average in the RAVLT Test; trials II, III, and VI (learning and immediate verbal memory). The patient showed no changes in performance in the RAVLT Test trials I, Interference, and VII (attention span, interference, and verbal delayed recall, respectively), CPT II Test (to assess sustained attention), and Digit Span Test; total number of correct sequences Forward and Backward (working memory). The patient showed better performance in the Forward than in the Backward Digit Span, The Category Test (Animals) assesses semantic fluency and LNS test (working memory) were only administered during the second neuropsychological evaluation.
Abbreviations: CPT, Continuous Performance Test; FAS, one form of the Controlled Oral Word Association Test using the letters F, A, and S; LNS, Letter-Number Sequencing; MMSE, Mini-Mental State Exam; RAVLT, Rey Auditory Verbal Learning Test; ROCF, Rey-Osterrieth Complex Figure Test; TMT, Trail Making Test; WAIS, Wechsler Adult Intelligence Scale; WCST, Wisconsin Card Sorting Test.